Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.925
Bid: 35.70
Ask: 36.15
Change: 0.00 (0.00%)
Spread: 0.45 (1.261%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 35.925
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Interest in Shares

3 Sep 2012 17:36

RNS Number : 4017L
Futura Medical PLC
03 September 2012
 



For immediate release

3 September 2012

 

Futura Medical plc

("Futura" or "the Company")

TR-1: Notification of major interest in shares

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Futura Medical

 

2. Reason for the notification (please tick the appropriate box or boxes)

 

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify): Transfer into Nominees

x

 

3. Full name of person(s) subject to the notification obligation:

Investec Wealth & Investment Limited

 

4. Full name of shareholder(s)

(if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached if different:

28th August 2012

 

6. Date on which issuer notified:

3rd September 2012

 

7. Threshold(s) that is/are crossed:

4%

 

 

8.Notified details: Nominee holdings

A: Voting rights attached to shares

Class/type of

Shares

 

if possible using

the ISIN CODE

Situation previous

to the triggering

transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

3327847

1,863,240

1,863,240

3,018,485

4.09%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,018,485

4.09%

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Phil Beardwell Chartered FCSI

Senior Compliance Manager

15. Contact telephone number:

020 7597 1356

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGUAWBUPPGQW
Date   Source Headline
3rd Dec 20181:00 pmRNSTotal Voting Rights
30th Nov 20188:54 amRNSBlock listing update
26th Nov 20186:00 pmRNSApplication for Block Listing
19th Nov 20183:43 pmRNSHolding(s) in Company
19th Nov 20182:29 pmRNSHolding(s) in Company
19th Nov 20182:24 pmRNSHolding(s) in Company
19th Nov 201811:03 amRNSDirectors' / PDMR Dealing and Grant of Options
15th Nov 201811:36 amRNSHolding(s) in Company
13th Nov 20187:00 amRNSDirector/PDMR Dealings
12th Nov 20182:17 pmRNSResult: Open Offer General Meeting & Voting Rights
9th Nov 20187:00 amRNSPresents Data on MED2005 at SMSNA Annual Meeting
6th Nov 20188:29 amRNSHolding(s) in Company
31st Oct 20187:00 amRNS1st Patient Enrolled in European Ph3 MED2002 study
24th Oct 201810:19 amRNSPosting of Circular and Notice of General Meeting
19th Oct 20189:05 amRNSSecond Price Monitoring Extn
19th Oct 20189:00 amRNSPrice Monitoring Extension
19th Oct 20187:00 amRNSFurther Details on the Fundraising
18th Oct 20185:16 pmRNSOffer on PrimaryBid.com
18th Oct 20185:04 pmRNSProposed Fundraising
1st Oct 20187:00 amRNSHolding(s) in Company
26th Sep 20187:00 amRNSInterim Results for the Six Months 30 June 2018
24th Sep 20183:39 pmRNSTR-1: Notification of major holdings
24th Sep 20187:00 amRNSHolding(s) in Company
24th Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20184:41 pmRNSSecond Price Monitoring Extn
20th Sep 20184:35 pmRNSPrice Monitoring Extension
19th Sep 20189:05 amRNSSecond Price Monitoring Extn
19th Sep 20189:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSBusiness Update
29th Aug 20187:00 amRNSNotice of Interim Results
23rd Jul 20187:00 amRNSTPR 100: UK Regulatory Submission
13th Jun 20186:22 pmRNSResult of AGM
13th Jun 20187:00 amRNSAGM Statement
31st May 20186:20 pmRNSTotal Voting Rights
30th May 201810:20 amRNSBlock Listing Interim Review
25th May 20187:00 amRNSApplication for Block Listing
27th Apr 20185:11 pmRNSNotification of Major Interest in Shares
26th Apr 20187:00 amRNSPhase III efficacy study of MED2002
25th Apr 20187:00 amRNSPositive data from MED2002 PK study
6th Apr 201812:13 pmRNSNotice of AGM
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20187:00 amRNSPositive Interim Data from MED2002 PK study
20th Feb 20187:00 amRNSDirectorate Changes
15th Feb 20187:00 amRNSNotification of Preliminary Results
31st Jan 201810:39 amRNSTotal Voting Rights
4th Jan 20187:00 amRNSPublication of Positive MED2002 Clinical Data
3rd Jan 20183:08 pmRNSDirector/PDMR Shareholding
2nd Jan 20183:50 pmRNSRemuneration of Non-Executive Directors and TVR
29th Nov 20177:00 amRNSMED2002: Regulatory, Clinical & Commercial Update
29th Nov 20177:00 amRNSMED2002: PK Study Commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.